Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
850.00    34.00 (4.17%)
Bid:
844.00
Ask:
852.00
Spread: 8.00 (0.948%)
Market Cap: £391.82m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Pre-close Trading Update and Acquisition

8 Dec 2017 07:00

RNS Number : 7434Y
Porvair PLC
08 December 2017
 

For immediate release 8 December 2017

 

 

Porvair PLC

 

Pre-close trading update and acquisition

 

Porvair plc ("Porvair", "the Group" or "the Company"), the specialist filtration and environmental technologies group, announces the following trading update and acquisition ahead of its close period for the year ended 30 November 2017.

Trading update

Revenue growth for the year ended 30 November 2017 was 6%. Underlying revenue(1) growth was 11% overall, with underlying revenue growth of 13% in the Microfiltration division and 1% in the Metals Filtration division. Earnings for the year are forecast to be ahead of management's expectations.

Net cash at the 30 November 2017 was £9.7 million (2016: £13.6 million), after capital and acquisition expenditure of approximately £11 million. Group order books for the start of the 2018 financial year are healthy. 

New divisional structure

Recognising the Group's growth in recent years, and as noted in the 2017 interim report, the Board will change the Group's management and reporting structure in 2018 to one that offers better management and market focus and greater investor clarity. The 2017 Report and Accounts will use the current two division structure, but will include proforma information for the new three new divisions, which will serve distinct markets: Aerospace & Industrial; Laboratory; and Molten Metals.

Acquisition

The new Laboratory division, which will focus on filtration and sample preparation products, acquired Rohasys B.V., a Dutch company, on 7 December 2017. This small acquisition brings robotic sample handling expertise to the division, which will enhance the Group's growing bioscience sample preparation capabilities.

Date of preliminary announcement

Porvair will announce its preliminary results for the year ended 30 November 2017 on Monday 29 January 2018.

Market Abuse Regime

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

Note (1) Underlying revenue: Revenue at constant currency excluding the impact of large projects.

 

For further information, please contact:

Porvair plc

 

01553 765 500

Ben Stocks, Chief Executive

 

 

Chris Tyler, Group Finance Director

 

 

Buchanan Communications

 

0207 466 5000

Charles Ryland / Steph Watson

 

 

 

Notes to editors

 

Porvair plc

Porvair is a group of specialist filtration, separation and environmental technologies businesses. Its products are used in a range of niche filtration and separation markets, and are derived from its expertise in the design and manufacture of filtration and separation systems. From the 2018 financial year it is organised into three divisions: Aerospace & Industrial; Laboratory; and Molten Metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUBUNRBAAURAA
Date   Source Headline
23rd Aug 20114:59 pmRNSHolding(s) in Company
20th Jul 20114:17 pmRNSBlocklisting Application
1st Jul 20114:45 pmRNSDirector/PDMR Shareholding
29th Jun 20117:00 amRNSDirector/PDMR Shareholding
27th Jun 20117:00 amRNSInterim Results
16th Jun 20117:00 amRNSAppointment of Corporate Broker
2nd Jun 20117:00 amRNSTrading Update
5th Apr 20113:20 pmRNSAGM resolutions and notice of filings
5th Apr 20117:00 amRNSAGM / Interim Management Statement
4th Mar 20112:10 pmRNSPosting of Annual Report and Accounts
2nd Feb 20112:50 pmRNSDirectors' Shareholdings and Issue of Equity
25th Jan 20117:00 amRNSPreliminary Results
24th Dec 201012:20 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTrading Update
19th Nov 20107:00 amRNSContract Win
28th Sep 20107:00 amRNSContract Win
17th Sep 20105:04 pmRNSHolding(s) in Company
14th Sep 20107:00 amRNSInterim Management Statement
9th Jul 201010:49 amRNSHolding(s) in Company
2nd Jul 20107:00 amRNSDirector/PDMR Shareholding
29th Jun 20104:25 pmRNSDirector/PDMR Shareholding
29th Jun 20107:00 amRNSHalf Yearly Report
8th Jun 20102:30 pmRNSHolding(s) in Company
2nd Jun 20107:00 amRNSTrading Update
5th May 20104:10 pmRNSHolding(s) in Company
26th Apr 20104:13 pmRNSHolding(s) in Company
26th Apr 20107:00 amRNSNew aluminium contract win
13th Apr 20102:59 pmRNSAGM resolutions and notice of filing
13th Apr 20107:00 amRNSAGM/Interim Management Statement
23rd Mar 20107:00 amRNSOrders for new Seal product
10th Feb 20107:00 amRNSPorvair wins new nuclear filtration orders
26th Jan 20107:00 amRNSPreliminary Results
10th Dec 20092:56 pmRNSHolding(s) in Company
2nd Dec 20094:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20094:35 pmRNSPrice Monitoring Extension
2nd Dec 20091:00 pmRNSHolding in Company
2nd Dec 20097:00 amRNSTrading update
18th Nov 20097:00 amRNSAnnual Information Update
21st Oct 200912:32 pmRNSHolding(s) in Company
21st Oct 200911:00 amRNSDirector/PDMR Shareholding
13th Oct 20097:00 amRNSInterim Management Statement
8th Jul 200910:15 amRNSDirector/PDMR Shareholding
1st Jul 20091:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20097:00 amRNSInterim Results
4th Jun 20097:00 amRNSTrading update
20th May 200911:52 amRNSHolding(s) in Company
19th May 20094:36 pmRNSHolding(s) in Company
19th May 20098:47 amRNSAcquisition of a significant interest in Porvair
23rd Apr 20097:00 amRNSNew Aluminum Cast House Filter
7th Apr 20094:45 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.